Pralidoxime
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Department of National Defence, acting for the Canadian Forces Health Services Group, is seeking a supplier to provide Pralidoxime for the treatment of personnel exposed to chemical warfare agents. The initial procurement requires 450 doses to be delivered by March 31, 2027, with an option for an additional 600 doses to be delivered between April 1, 2027, and March 31, 2031. This solicitation, identified as W6369-26-A033/B, is open to Canadian suppliers and those from applicable trading partners, with a response deadline of November 10, 2026. There are no security requirements associated with this contract, and submissions are accepted in either official language of Canada. The primary point of contact for this requirement is Stephen Brown.
General Info
Place of Performance
Canada, South America, United States of America, Mexico, Africa, Asia, Caribbean, Central America, Europe, Oceania, Aboriginal , CANSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Government of Canada → Department of National Defence
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
